Clinical trial
A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients…
NCT00002067 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00002067 |
|---|---|
| Title | A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia |
| Official title | Phase III Randomized Double-Blind Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anorexia, Cachexia, HIV Infections |
| Intervention type | Drug |
| Interventions | Megestrol acetate |
| First posted | Aug 31, 2001 |
| Last update posted | Oct 2, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: